✦ LIBER ✦

Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity

✍ Scribed by Akito Natsume; Yukiko Shimizu-Yokoyama; Mitsuo Satoh; Kenya Shitara; Rinpei Niwa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel anti-CD20 antibody TGLA with enhan

✍ Ming Lv; Zhou Lin; Chunxia Qiao; Shusheng Gen; Xiaoling Lang; Yan Li; Jiannan Fe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 649 KB

Characterization of a humanized anti-CD2

✍ Lan Wu; Chong Wang; Dapeng Zhang; Xunming Zhang; Weizhu Qian; Lei Zhao; Hao Wang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 781 KB

Development of novel tetravalent anti-CD

✍ Yajun Guo; Bohua Li; Shu Shi; Hao Wang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A complement-dependent cytotoxicity-enha

✍ Fumihiko Sato; Asahi Ito; Takashi Ishida; Fumiko Mori; Hisashi Takino; Atsushi I 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 744 KB

T cells armed with anti-CD3 × anti-CD20

✍ Jonathan M. Gall; Pamela A. Davol; Ryan C. Grabert; Mark Deaver; Lawrence G. Lum 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 317 KB

T-cell activation induced by anti-CD3 ×

✍ James E. Wooldridge; Chris E. Dahle; George J. Weiner 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 306 KB